Cancer treatment method

Details for Australian Patent Application No. 2005251769 (hide)

Owner SmithKline Beecham (Cork) Limited

Inventors Berger, Mark S.; Gilmer, Tona Morgan; Pandite, Arundathy Nirmalini

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005251769

PCT Pub. Number WO2005/120512

Priority 60/577,337 04.06.04 US

Filing date 3 June 2005

Wipo publication date 22 December 2005

Acceptance publication date 2 October 2008

International Classifications

A61K 31/45 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/47 (2006.01) - Quinolines

A61K 31/4745 (2006.01)

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/7068 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

14 December 2006 PCT application entered the National Phase

  PCT publication WO2005/120512 Priority application(s): WO2005/120512

2 October 2008 Application Accepted

  Published as AU-B-2005251769

29 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005251772-System and method for transdermal delivery of an anticoagulant

2005251766-N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators